Werfen, announced that it has received the CE ( Conformité EuropéenneAptiva Immunoglobulin G ( IgG ) and Immunoglobulin M ( IgM ) Reagents for Antiphospholipid Syndrome ( APS ). under the European Union ( EUVitro Diagnostic Medical Devices Regulation ( IVDR ) .
Aptiva...
Werfen, announced 510(k) clearance of Aptiva Connective Tissue Disease (CTD) Essential reagent by the US Food and Drug Administration (FDA).
The Aptiva CTD Essential complements...
Werfen announced the 510(k) clearance of the ROTEM sigma Thromboelastometry System by the US Food and Drug Administration (FDA). The ROTEM sigma delivers real-time,...
Werfen, a worldwide leader in specialized diagnostics for autoimmune disease, is pleased to announce the CE Mark of Aptiva® CTD Essential Reagent for use...
